Evidence map›Paper›PMID 41053663›Full record

ArticleBMC cancer2025

AI-driven chemotoxicity prediction in colorectal cancer: impact of race, SDOH, and biological aging.

Claire Han, Christin Burd, Jesse Plascak, Fode Tounkara, Ashley Rosko, Anne Noonan, Alai Tan, Diane Von Ah, Xia Ning

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire HanCenter for Healthy Aging, Self-Management and Complex Care, Ohio State University College of Nursing, The Ohio State University, Cancer Treatment and Research Center, Columbus, OH, 43210, United States of America. Han.1985@osu.edu.
Christin BurdDepartments of Molecular Genetics, Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, United States of America.
Jesse PlascakDivision of Cancer Prevention and Control, Ohio State University College of Medicine, The Ohio State University, Comprehensive Cancer Center Columbus, Columbus, OH, 43210, United States of America.
Fode TounkaraDepartment of Biomedical Informatics and Biostatistics, Cancer Treatment and Research Center, Ohio State University College of Medicine, The Ohio State University, Columbus, OH, 43210, United States of America.
Ashley RoskoDivision of Hematology, The Ohio State University, Columbus, OH, United States of America.
Anne NoonanSection Chief, GI Medical Oncology Section, Cancer Treatment and Research Center, The Ohio State University, Columbus, OH, 43210, United States of America.
Alai TanCenter for Healthy Aging, Self-Management, and Complex Care, Office of Research, Biostatistics, College of Nursing Columbus, The Ohio State University, Columbus, OH, 43210, USA.
Diane Von AhCenter for Healthy Aging, Self-Management, and Complex Care, College of Nursing, Codirector of Cancer Survivorship and Control Group, Cancer Treatment and Research Center, The Ohio State University, Columbus, OH, 43210, United States of America.
Xia NingClinical Informatics and Implementation Science Biomedical Informatics (BMI), College of Medicine. Computer Science and Engineering (CSE), College of Engineering, The Ohio State University, Columbus, OH, 43210, United States of America.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

backgroundPatients with colorectal cancer (CRC) often experience chemotoxicity that impacts treatment adherence, survival, and quality of life. Early screening for chemotoxicity risk is vital, yet comprehensive predictive models are lacking. The objective of this study was to develop effective artificial intelligence (AI)/machine learning (ML) models, integrating racialized group, social determinants of health (SDOH) (Area Deprivation Index [ADI], employment status), and biological aging (Levine Phenotypic Age) to predict overall, gastrointestinal (GI), and hematological chemotoxicity.

methodsWe used electronic health records data from 1,735 adult patients with CRC. Sociodemographic/clinical variables, Levine Phenotypic Age (biological aging), and SDOH (including geospatial variations measured by ADI) were analyzed using descriptive statistics. Associations with chemotoxicity (overall, GI, hematological) were evaluated via univariate tests. Significant predictors from univariate tests were selected for AI/ML modeling. Six supervised ML models were trained on 80% of cases (n = 1,388), with 20% (n = 347) reserved for testing. Performance was assessed via accuracy, area under the curve (AUC), and F1-score. Permutation feature importance ranked predictors to define the most significant predictors of chemotoxicity.

resultsSupport Vector Machine and XGBoost models demonstrated high accuracy in both the training and test datasets. Notably, the AUC (0.988) was highest for the Support Vector Machine model in predicting overall chemotoxicity within the training dataset. Key predictors of overall and GI toxicities included higher Levine Phenotypic Age, elevated inflammatory markers (e.g., C-reactive protein), and poor SDOH (e.g., higher ADI, unemployment). Hematological toxicity was linked to lower inflammatory markers, higher Levine Phenotypic Age, and younger chronological age. Race (non-Hispanic Black), body mass index, and lifestyle also influenced overall and GI toxicities.

conclusionsML-based chemotoxicity prediction models incorporating racialized group, SDOH, and biological aging had high accuracy. Greater biological aging, poor SDOH including ADI, and higher inflammation markers were common risk factors for overall and GI chemotoxicity. In contrast, chronological and biological ages and immune/inflammation markers were only linked to hematological chemotoxicity. Integrating these factors into predictive models can help clinicians identify at-risk patients and tailor interventions (e.g., anti-inflammatory, anti-aging strategies) to reduce chemotoxicity and improve survivorship outcomes.

Indexed as

AgingAntineoplastic AgentsArtificial IntelligenceColorectal NeoplasmsAdultAgedFemaleHumansMachine LearningMaleMiddle AgedPredictive Learning ModelsRacial GroupsAntineoplastic AgentsArtificial intelligenceBiological agingChemotoxicityColorectal cancerGeospatial variationsMachine learningPredictionRisk factorsSocial determinants of health

Identifiers

PMID41053663
PMCPMC12502520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.